Recruiting

Culturally Adapted CBTI

Sponsor:

UCLA

Code:

NCT07387406

Conditions

Insomnia Chronic

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Not accepted

Interventions

CBT-I based sleep intervention

Sleep Education

Study Details

Brief summary:

Poor sleep is common among Asian Americans. Untreated sleep problems increase the risk of chronic diseases, cognitive decline, and mortality. Cognitive behavioral therapy for insomnia (CBTI) is considered the first-line treatment for chronic sleep problems and has demonstrated significant improvement in sleep health among older adults. However, existing CBTI is built upon Western culture, making it challenging to apply for Asian immigrants who maintain close ties to their native cultures that shape and influence their sleep habits. Addressing the lack of availability of a culturally adapted sleep intervention program is the first step to filling the gap in sleep health disparity among Asian immigrants.

This study aims to pilot test the feasibility and the preliminary efficacy of a culturally adapted sleep intervention program among older Korean immigrants with poor sleep, one of the fastest-growing immigrant groups in the United States with limited access to mainstream sleep therapies.

Conditions

Insomnia Chronic

Study ID

NCT07387406

Start date

Feb 24, 2026

Status verified date

Mar, 2026

Completion date

Jan 4, 2027

Anticipated

Primary completion date

Dec 31, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Korean immigrants (i.e., being a resident of the United States with a birthplace in Korea)
  • Able to speak, read, and write in Korean
  • Aged at least 60 years
  • Have a score of at least 15 on a Korean version of the Insomnia Severity Index
  • Able to ambulate with or without an assistive device
  • Have a score of at least 23 on a Korean version of the Montreal Cognitive Assessment (MoCA)
  • Score less than 5 on STOP-BANG (or proceed with an additional testing \[Watch Peripheral Arterial Tonometry (WatchPAT) and the Epworth Sleepiness Scale if score is equal to or greater than 5 on STOP-BANG)

Exclusion Criteria:

  • Those who are bedbound
  • Those who do not meet the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria for insomnia disorder
  • Those who have an untreated apnea-hypopnea index (AHI) at least 15 (moderate obstructive sleep apnea) and Epworth Sleepiness Scale (ESS) at least 11 (indicating mild sleepiness) OR AHI is equal to or greater than 30 (irrespective of ESS)

Study Design

Enrollment

32 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: Sleep Intervention Program

This is a culturally adapted sleep education program built upon key components of cognitive behavioral therapy for insomnia (CBT-I)

placebo comparator: Control

This involves with general information about sleep

Interventions

CBT-I based sleep intervention

A multicomponent behavioral sleep program, consisting of sleep compression, stimulus control, sleep hygiene, relaxation, daily physical activity, and light exposure

Sleep Education

This group will receive information about sleep and aging, but without specific or individualized recommendations

Primary outcome measure

  • Objective Sleep Efficiency [ Time Frame: Immediately after the last session of the intervention ]
  • Subjective Sleep Quality [ Time Frame: Immediately after the last session of the intervention ]

Central Contacts and Locations

Central contacts

Locations

University of California Los Angeles

Recruiting

Los Angeles, California, United States, 90095

Contacts

More Information

Sponsor

University of California, Los Angeles

Last update posted

Mar 5, 2026

Last verified

Mar, 2026

Keywords

  • older Korean Americans
  • sleep
  • behavioral approach

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of California, Los Angeles on 2026-03-05.